点击微球时代，创领介入未来！
Objective:Toevaluatethefeasibilityandsafetyoftransarterialchemoembolizationwithdrugelutingbeads(DEB-TACE)inpatientswithhepatocellularcarcinoma(HCC)andarterioportalshunts(APSs).
目的：探讨使用载药微球行经动脉化疗栓塞(DEB-TACE)治疗肝细胞癌(HCC)合并肝动脉门静脉分流(APSs)患者的可行性和安全性。
Materialsandmethods:Fifty-eightpatientswithunresectableHCCandAPSswhoweretreatedwithDEB-TACE(n=26)orpolyvinylalcohol(PVA)plusTACE(PVA-TACE,n=32)wereincludedinthisretrospectivestudy.ThetumorresponsewasevaluatedbythemodifiedResponseEvaluationCriteriainSolidTumors.ToxicitywasgradedbytheCommonTerminologyCriteriaforAdverseEventsversion5.0(CTCAEv5.0)and